Ionis Pharmaceuticals (IONS) Equity Ratio (2016 - 2025)
Ionis Pharmaceuticals (IONS) has 17 years of Equity Ratio data on record, last reported at 0.2 in Q3 2025.
- For Q3 2025, Equity Ratio fell 5.24% year-over-year to 0.2; the TTM value through Sep 2025 reached 0.2, down 5.24%, while the annual FY2024 figure was 0.2, 51.46% up from the prior year.
- Equity Ratio reached 0.2 in Q3 2025 per IONS's latest filing, down from 0.21 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.3 in Q1 2021 and bottomed at 0.1 in Q2 2024.
- Average Equity Ratio over 5 years is 0.2, with a median of 0.21 recorded in 2025.
- Peak YoY movement for Equity Ratio: crashed 56.19% in 2023, then surged 115.97% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.3 in 2021, then decreased by 23.49% to 0.23 in 2022, then plummeted by 42.8% to 0.13 in 2023, then skyrocketed by 51.46% to 0.2 in 2024, then rose by 4.02% to 0.2 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.2 in Q3 2025, 0.21 in Q2 2025, and 0.17 in Q1 2025.